InvestorsHub Logo
Followers 409
Posts 18402
Boards Moderated 2
Alias Born 10/20/2011

Re: None

Thursday, 04/09/2020 9:42:29 AM

Thursday, April 09, 2020 9:42:29 AM

Post# of 35961
$NSPX -Mipsagargin demonstrated an acceptable tolerability and favorable pharmacokinetic profile in patients with solid tumors. #cancer #treatment Inspyr Therapeutics (@InspyrTheraputx) February 25, 2020